Agilon Health, INC 10-Q quarterly reports

agilon health, inc. announced the appointment of Tim O'Rourke as CEO and reported a significant increase in net income and Adjusted EBITDA for the first quarter of 2026, despite a decrease in total revenue.

Agilon Health reported a net loss of $110 million in Q3 2025, with declining Medicare Advantage membership and significant year-to-date financial deterioration.

Agilon Health reported a significant increase in net losses and a decline in total revenues for the second quarter and first half of 2025, driven by lower membership and rising medical expenses per member.

Agilon Health's Q1 2025 results show a rise in net income to $12 million, despite a decrease in total revenue to $1.5 billion.

Agilon Health's Q3 2024 results show a significant increase in revenue, but also a substantial rise in medical expenses, leading to a net loss.

Agilon Health's second quarter 2024 results show a significant increase in revenue and membership, but also a net loss and a decrease in gross profit compared to the same period last year.

Agilon Health's first quarter saw a significant increase in membership and revenue, but also a net loss and ongoing legal proceedings.